[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Recall of Interferon alfa-2b, (Recombinant), Powder for Injection, INTRON A


DATE RECALL INITIATED:

October 22, 2001

PRODUCT / LOT NUMBER / EXPIRATION DATE:

PAK-3
Carton Lot No.
Interferon
Vial Lot No.
Expiration Date
9-CO-3 8-IFB-005 10/20/01
9-CO-6 8-IFB-006 11/04/01
0-CO-10 8-IFB-006 11/04/01
0-CO-11 8-IFB-007 11/23/01
1-CO-11 9-IFB-001 08/02/02

MANUFACTURER:

Schering Corporation
Kenilworth, NJ

REASON:

Lots 8-IFB-005, 8-IFB-006, and 8-IFB-007 were found to be subpotent, after assaying as 87%-89%, at 30 days following reconstitution with sterile Bacteriostatic Water for Injection. Lot 9-IFB-001 was withdrawn as a precautionary measure because of the potential that this batch would not meet the product quality specification for assay prior to its expiration date. All of the lots are within the product quality specification for assay when tested immediately upon reconstitution.


The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.


Last Updated: 4/4/2002

 

Back to Top     Back to Index

Updated: September 26, 2003

horizonal rule